Proton relaxation enhancement
- PMID: 8428082
- DOI: 10.1002/jmri.1880030127
Proton relaxation enhancement
Abstract
Paramagnetic and superparamagnetic substances are used as contrast agents to enhance proton relaxation in magnetic resonance imaging. This review summarizes the physics of contrast agents, specifically the mechanisms by which contrast agents enhance T1 and T2 relaxation. The purpose is to provide a background for understanding the behavior of existing contrast agents in basic experimental and clinical studies. Terms such as magnetic dipole, dipole moment, magnetic susceptibility, diamagnetism, paramagnetism, superparamagnetism, and ferromagnetism are introduced. Two important interactions between the magnetic dipole moments of paramagnetic substances and the dipole moments associated with protons are described. The Solomon-Bloembergen-Morgan equations and other basic relaxation theory that has been confirmed experimentally are introduced to account for the dependence of relaxation on such parameters as the Larmor frequency, magnetic moment, accessibility of water molecules to the core of a contrast agent, and frequency of molecular motions.
Similar articles
-
Basic physics of MR contrast agents and maximization of image contrast.J Magn Reson Imaging. 1993 Jan-Feb;3(1):137-48. doi: 10.1002/jmri.1880030126. J Magn Reson Imaging. 1993. PMID: 8428081 Review.
-
Basic principles of MR contrast.Top Magn Reson Imaging. 1995 Summer;7(3):124-36. Top Magn Reson Imaging. 1995. PMID: 7654392 Review.
-
Role of spatial distribution in proton relaxation enhancement by particulate iron oxide.Invest Radiol. 1994 Jun;29 Suppl 2:S78-80. doi: 10.1097/00004424-199406001-00026. Invest Radiol. 1994. PMID: 7523329 No abstract available.
-
Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide.J Magn Reson Imaging. 1994 Sep-Oct;4(5):653-7. doi: 10.1002/jmri.1880040506. J Magn Reson Imaging. 1994. PMID: 7526912
-
Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.Invest Radiol. 1996 Nov;31(11):696-708. doi: 10.1097/00004424-199611000-00004. Invest Radiol. 1996. PMID: 8915751 Clinical Trial.
Cited by
-
The optimal use of contrast agents at high field MRI.Eur Radiol. 2006 Jun;16(6):1280-7. doi: 10.1007/s00330-006-0154-0. Epub 2006 Mar 1. Eur Radiol. 2006. PMID: 16508769 Review.
-
Dual Contrast - Magnetic Resonance Fingerprinting (DC-MRF): A Platform for Simultaneous Quantification of Multiple MRI Contrast Agents.Sci Rep. 2017 Aug 16;7(1):8431. doi: 10.1038/s41598-017-08762-9. Sci Rep. 2017. PMID: 28814732 Free PMC article.
-
Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI.Neuroimage. 2013 Jan 1;64:693-702. doi: 10.1016/j.neuroimage.2012.08.065. Epub 2012 Aug 31. Neuroimage. 2013. PMID: 22960250 Free PMC article.
-
Structure-Relaxivity Relationships of Magnetic Nanoparticles for Magnetic Resonance Imaging.Adv Mater. 2019 Feb;31(8):e1804567. doi: 10.1002/adma.201804567. Epub 2019 Jan 2. Adv Mater. 2019. PMID: 30600553 Free PMC article. Review.
-
Cellular magnetic resonance imaging: nanometer and micrometer size particles for noninvasive cell localization.Neurotherapeutics. 2007 Jul;4(3):428-33. doi: 10.1016/j.nurt.2007.05.010. Neurotherapeutics. 2007. PMID: 17599708 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical